Market Place
Sourcing Support
All News #Library
Biotech
FDA Accepts Zipalertinib NDA for EGFR Exon 20 NSCLC Cancer
28 Apr 2026 //
PHARMIWEB
Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC
20 Nov 2025 //
PR NEWSWIRE
Taiho’s Inqovi Combo sNDA Accepted By US FDA For AML
09 Jul 2025 //
PR NEWSWIRE
Taiho`s DMD Asset Fails in Phase 3 Trial
08 Jul 2025 //
FIERCE BIOTECH
Taiho & Cullinan Announce Phase 1/2 Data Published
01 Jun 2025 //
PR NEWSWIRE
Cullinan, Taiho, and Taiho Oncology to Present Zipalertinib Trial
22 May 2025 //
GLOBENEWSWIRE
Taiho Pharmaceutical Acquires ADC Drug Discovery Company Araris
17 Mar 2025 //
GLOBENEWSWIRE
Otsuka`s Taiho pays $400M to buy Swiss ADC partner
17 Mar 2025 //
GLOBENEWSWIRE
Nuntius Partners With Taiho Pharma To Develop Next-Gen mRNA Therapies
15 Aug 2024 //
BUSINESSWIRE
FDA Approves LONSURF in Combination With Bevacizumab for mCRC
02 Aug 2023 //
PR NEWSWIRE
U.S. FDA Accepts for Priority Review Taiho Onc`s sNDA for Trifluridine/Tipiracil
18 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.